217 related articles for article (PubMed ID: 31381204)
21. Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas.
Ferguson SD; Zhou S; Huse JT; de Groot JF; Xiu J; Subramaniam DS; Mehta S; Gatalica Z; Swensen J; Sanai N; Spetzler D; Heimberger AB
J Neuropathol Exp Neurol; 2018 Jun; 77(6):437-442. PubMed ID: 29718398
[TBL] [Abstract][Full Text] [Related]
22. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
Richardson TE; Tang K; Vasudevaraja V; Serrano J; William CM; Mirchia K; Pierson CR; Leonard JR; AbdelBaki MS; Schieffer KM; Cottrell CE; Tovar-Spinoza Z; Comito MA; Boué DR; Jour G; Snuderl M
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1089-1099. PubMed ID: 31626289
[TBL] [Abstract][Full Text] [Related]
23. Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions.
Wang L; Bhargava R; Zheng T; Wexler L; Collins MH; Roulston D; Ladanyi M
J Mol Diagn; 2007 Sep; 9(4):498-509. PubMed ID: 17690209
[TBL] [Abstract][Full Text] [Related]
24. The utility of ETV1, ETV4 and ETV5 RNA in-situ hybridization in the diagnosis of CIC-DUX sarcomas.
Smith SC; Palanisamy N; Martin E; Almenara J; McHugh JB; Choi EK; Lucas DR; Betz BL; Thomas D; Patel RM
Histopathology; 2017 Mar; 70(4):657-663. PubMed ID: 27790742
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a rare
Deland L; Keane S; Olsson Bontell T; Sjögren H; Fagman H; Øra I; De La Cuesta E; Tisell M; Nilsson JA; Ejeskär K; Sabel M; Abel F
Cancer Biol Ther; 2021 Mar; 22(3):184-195. PubMed ID: 33820494
[TBL] [Abstract][Full Text] [Related]
26. Identification of MET fusions in solid tumors: A multicenter, large scale study in China.
Yang W; Zhao X; Zheng A; Liu Z; Ma J; Zhang X; Li W; Wang D; Zhu J; Tao H; Zhang Y; Ma T; Liu Q
Int J Cancer; 2023 Mar; 152(6):1259-1268. PubMed ID: 36408924
[TBL] [Abstract][Full Text] [Related]
27. Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.
Hermans KG; van der Korput HA; van Marion R; van de Wijngaart DJ; Ziel-van der Made A; Dits NF; Boormans JL; van der Kwast TH; van Dekken H; Bangma CH; Korsten H; Kraaij R; Jenster G; Trapman J
Cancer Res; 2008 Sep; 68(18):7541-9. PubMed ID: 18794142
[TBL] [Abstract][Full Text] [Related]
28. Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.
Granberg KJ; Annala M; Lehtinen B; Kesseli J; Haapasalo J; Ruusuvuori P; Yli-Harja O; Visakorpi T; Haapasalo H; Nykter M; Zhang W
Neuro Oncol; 2017 Sep; 19(9):1206-1216. PubMed ID: 28379477
[TBL] [Abstract][Full Text] [Related]
29. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior.
Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779
[TBL] [Abstract][Full Text] [Related]
30. Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
Wong D; Yip S; Sorensen PH
Pathol Oncol Res; 2020 Jul; 26(3):1385-1399. PubMed ID: 31256325
[TBL] [Abstract][Full Text] [Related]
31. Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.
Pisapia DJ; Ohara K; Bareja R; Wilkes DC; Hissong E; Croyle JA; Kim JH; Saab J; MacDonald TY; Beg S; O'Reilly C; Kudman S; Rubin MA; Elemento O; Sboner A; Greenfield J; Mosquera JM
Acta Neuropathol Commun; 2020 Jun; 8(1):80. PubMed ID: 32493417
[TBL] [Abstract][Full Text] [Related]
32. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
33. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.
Kawamura-Saito M; Yamazaki Y; Kaneko K; Kawaguchi N; Kanda H; Mukai H; Gotoh T; Motoi T; Fukayama M; Aburatani H; Takizawa T; Nakamura T
Hum Mol Genet; 2006 Jul; 15(13):2125-37. PubMed ID: 16717057
[TBL] [Abstract][Full Text] [Related]
34. Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
Zeng AL; Yan W; Liu YW; Wang Z; Hu Q; Nie E; Zhou X; Li R; Wang XF; Jiang T; You YP
Oncogene; 2017 Sep; 36(38):5369-5381. PubMed ID: 28504721
[TBL] [Abstract][Full Text] [Related]
35. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM
Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298
[TBL] [Abstract][Full Text] [Related]
36. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
[TBL] [Abstract][Full Text] [Related]
37. Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data.
Zwaig M; Baguette A; Hu B; Johnston M; Lakkis H; Nakada EM; Faury D; Juretic N; Ellezam B; Weil AG; Karamchandani J; Majewski J; Blanchette M; Taylor MD; Gallo M; Kleinman CL; Jabado N; Ragoussis J
BMC Cancer; 2022 Dec; 22(1):1297. PubMed ID: 36503484
[TBL] [Abstract][Full Text] [Related]
38.
Jones KA; Bossler AD; Bellizzi AM; Snow AN
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936198
[TBL] [Abstract][Full Text] [Related]
39. PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma.
Makinoshima H; Ishii G; Kojima M; Fujii S; Higuchi Y; Kuwata T; Ochiai A
BMC Cancer; 2012 Nov; 12():537. PubMed ID: 23170925
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the activation of protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1) by hypoxia inducible factor-2 alpha.
Wang V; Davis DA; Veeranna RP; Haque M; Yarchoan R
PLoS One; 2010 Mar; 5(3):e9641. PubMed ID: 20224786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]